|
rs1000940
|
RABEP1
RABEP1 Metabolic-Immune Regulatory Variant
|
Intronic variant in RABEP1 associated with fasting glucose modulation under p...
|
Autoimmune Tolerance & T-Cell Regulation
|
|
Emerging
|
|
rs1008899
|
NEDD4L
|
Intronic NEDD4L variant tagging isoforms with differing ENaC ubiquitination c...
|
Blood Pressure & Hypertension
|
|
Moderate
|
|
rs10305420
|
GLP1R
Pro7Leu
|
GLP-1 receptor signal peptide variant that enhances semaglutide and tirzepati...
|
Pharmacogenomics
|
|
Moderate
|
|
rs10509679
|
CYP2C9
|
Intronic CYP2C9 haplotype tag associated with increased ischemic stroke risk ...
|
Coronary Artery Disease & Atherosclerosis
|
|
Emerging
|
|
rs10305492
|
GLP1R
A316T
|
Rare protective missense variant in the GLP-1 receptor associated with lower ...
|
Pharmacogenomics
|
|
Strong
|
|
rs10403955
|
CYP2B6
|
Intronic CYP2B6 haplotype-tagging variant associated with altered plasma conc...
|
Pharmacogenomics
|
|
Moderate
|
|
rs11854484
|
SLC28A2
SLC28A2 Pro22Leu
|
Missense variant in the concentrative nucleoside transporter 2 (CNT2) gene th...
|
Vitamins & Nutrient Absorption
|
|
Moderate
|
|
rs1042044
|
GLP1R
Leu260Phe
|
GLP-1 receptor variant in intracellular loop 2 that alters receptor surface e...
|
Pharmacogenomics
|
|
Moderate
|
|
rs12188300
|
IL12B
|
Near-gene variant at the IL12B locus associated with psoriasis risk through a...
|
Psoriasis & Spondyloarthropathy
|
|
Moderate
|
|
rs1045642
|
ABCB1
C3435T
|
Synonymous variant in P-glycoprotein affecting drug efflux pump expression an...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1805123
|
KCNH2
K897T
|
Common KCNH2 missense variant that alters hERG potassium channel kinetics, sh...
|
Arrhythmia & Heart Rhythm
|
|
Strong
|
|
rs199473521
|
KCNH2
K595N
|
Ultra-rare KCNH2 missense variant substituting asparagine for lysine at posit...
|
Arrhythmia & Heart Rhythm
|
|
Moderate
|
|
rs1058164
|
CYP2D6
|
Synonymous CYP2D6 variant that promotes exon 3 skipping, reducing functional ...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1058932
|
CYP2C8
|
CYP2C8 3-prime UTR variant associated with cardiovascular risk via altered ep...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1800975
|
XPA
A23G
|
5' UTR variant in the XPA DNA damage recognition gene that modulates nucleoti...
|
Cancer Risk
|
|
Strong
|
|
rs2032582
|
ABCB1
G2677T/A (Ser893Ala/Thr)
|
Triallelic missense variant in the P-glycoprotein efflux pump that reduces th...
|
Gamete Quality & DNA Repair
|
|
Moderate
|
|
rs11572325
|
CYP2J2
|
Intronic CYP2J2 variant associated with increased myocardial infarction risk ...
|
Vascular Inflammation & Remodeling
|
|
Moderate
|
|
rs28937317
|
SCN5A
N1325S
|
Rare gain-of-function missense variant in the cardiac sodium channel Nav1.5 c...
|
Arrhythmia & Heart Rhythm
|
|
Established
|
|
rs1080985
|
CYP2D6
*2A promoter
|
CYP2D6 promoter variant (-1584C>G) that reduces enzyme expression; the C alle...
|
Pharmacogenomics
|
|
Strong
|
|
rs1113129
|
CYP2C8
|
Intronic tagging SNP for CYP2C8 haplotype C, a low-activity haplotype associa...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1142345
|
TPMT
*3C
|
No-function variant causing deficient thiopurine methylation; most common TPM...
|
Pharmacogenomics
|
|
Established
|
|
rs116855232
|
NUDT15
Arg139Cys
|
Nucleotide diphosphatase that inactivates toxic thiopurine metabolites; reduc...
|
Pharmacogenomics
|
|
Established
|
|
rs2968864
|
KCNH2
KCNH2 QT interval GWAS variant (7q36.1)
|
Intergenic variant at 7q36.1 near KCNH2 (hERG potassium channel) that modulat...
|
Arrhythmia & Heart Rhythm
|
|
Strong
|
|
rs2317676
|
ITGB3
|
3' UTR variant in the platelet glycoprotein IIIa gene (ITGB3/GPIIIa) that dis...
|
Von Willebrand & Anticoagulant Proteins
|
|
Moderate
|
|
rs12721627
|
CYP3A4
*16
|
Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst...
|
Pharmacogenomics
|
|
Moderate
|
|
rs12721629
|
CYP3A4
*16B
|
Missense variant causing substrate-dependent reduced CYP3A4 activity, most pr...
|
Pharmacogenomics
|
|
Moderate
|
|
rs2293275
|
LHCGR
Asn312Ser (N312S)
|
Affects LH/hCG receptor sensitivity near a glycosylation site, influencing ov...
|
Fertility & Ovarian Function
|
|
Strong
|
|
rs1341162
|
CYP2C8
|
Intronic CYP2C8 haplotype-tagging variant linked to altered drug metabolism c...
|
Pharmacogenomics
|
|
Moderate
|
|
rs20455
|
KIF6
Trp719Arg
|
Missense variant in kinesin family member 6; the Arg allele was associated wi...
|
Coronary Artery Disease & Atherosclerosis
|
|
Moderate
|
|
rs1341164
|
CYP2C8
|
Intronic CYP2C8 variant tagging a haplotype associated with altered taxane dr...
|
Pharmacogenomics
|
|
Emerging
|
|
rs2413775
|
SLC28A2
|
Promoter variant that increases SLC28A2/CNT2 transcription via enhanced HNF1 ...
|
Vitamins & Nutrient Absorption
|
|
Emerging
|
|
rs5925
|
LDLR
LDLR Expression Co-variant
|
Synonymous variant in LDLR exon 13 that modulates mRNA splicing efficiency in...
|
Atherogenic Lipoproteins
|
|
Moderate
|
|
rs16947
|
CYP2D6
*2
|
Common CYP2D6 variant defining the *2 allele; previously considered normal-fu...
|
Pharmacogenomics
|
|
Strong
|
|
rs6008845
|
PPARA
PPARA intronic C/T
|
Regulatory PPARA variant where TT homozygotes with type 2 diabetes experience...
|
Atherogenic Lipoproteins
|
|
Strong
|
|
rs17002852
|
CYP2D6
|
Synonymous CYP2D6 variant that causes allele dropout in standard CYP2D6*3 gen...
|
Pharmacogenomics
|
|
Moderate
|
|
rs6511720
|
LDLR
Intron 1
|
Common regulatory variant in the LDL receptor gene affecting LDLR expression,...
|
Atherogenic Lipoproteins
|
|
Strong
|
|
rs1799971
|
OPRM1
A118G
|
Mu-opioid receptor variant affecting opioid response, pain sensitivity, and p...
|
Pharmacogenomics
|
|
Strong
|
|
rs25531
|
SLC6A4
A>G
|
Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and...
|
Mood & Behavior
|
|
Moderate
|
|
rs1800460
|
TPMT
*3B
|
Decreased-function variant causing reduced thiopurine methylation; pairs with...
|
Pharmacogenomics
|
|
Established
|
|
rs1800462
|
TPMT
*2
|
The original TPMT deficiency allele — a no-function star allele causing ~100-...
|
Pharmacogenomics
|
|
Established
|
|
rs1801272
|
CYP2A6
*2 (L160H)
|
Loss-of-function CYP2A6 variant that abolishes nicotine metabolism, slowing c...
|
Pharmacogenomics
|
|
Established
|
|
rs489693
|
MC4R
MC4R AIWG variant
|
Intergenic variant near MC4R with genome-wide significant association with an...
|
Appetite & Obesity
|
|
Strong
|
|
rs1934951
|
CYP2C8
|
Intronic CYP2C8 variant associated with paclitaxel-induced toxicity and bisph...
|
Pharmacogenomics
|
|
Moderate
|
|
rs72551348
|
UGT1A1
Q331R
|
Rare pathogenic missense variant in the UGT1A1 gene that severely reduces bil...
|
Uric Acid & Kidney Function
|
|
Strong
|
|
rs1934953
|
CYP2C8
|
Intronic CYP2C8 variant linked to epoxygenase pathway activity, hypertension ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs396991
|
FCGR3A
V158F
|
Missense variant in Fc gamma receptor IIIa (CD16a) that determines NK cell Ig...
|
Innate Immunity & Infection Defense
|
|
Strong
|
|
rs1934963
|
CYP2C9
|
Deep intronic CYP2C9 variant associated with altered drug response to sulfony...
|
Pharmacogenomics
|
|
Emerging
|
|
rs1934967
|
CYP2C9
|
Intronic CYP2C9 haplotype tag associated with altered warfarin sensitivity an...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3846662
|
HMGCR
HMGCR Intron 13 Splice Variant
|
Intronic HMGCR variant that modulates alternative splicing of exon 13, produc...
|
Cholesterol & Lipoproteins
|
|
Moderate
|
|
rs1934980
|
CYP2C8
|
Intronic CYP2C8 variant linked to altered enzyme expression and associated wi...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3846663
|
HMGCR
HMGCR Exon 13 Haplotype Tag
|
Intronic HMGCR variant that tags a haplotype influencing exon 13 alternative ...
|
Cholesterol & Lipoproteins
|
|
Strong
|
|
rs2069526
|
CYP1A2
-739T>G
|
Intronic CYP1A2 variant near the 5' end; G allele is associated with altered ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs2070672
|
CYP2E1
|
CYP2E1 promoter variant affecting enzyme expression and susceptibility to ace...
|
Pharmacogenomics
|
|
Moderate
|
|
rs2070676
|
CYP2E1
|
Intronic CYP2E1 variant tagging the *1B haplotype; C allele marks reduced CYP...
|
Pharmacogenomics
|
|
Moderate
|
|
rs6295
|
HTR1A
C-1019G
|
Functional promoter variant in the serotonin 1A receptor gene that increases ...
|
Mood & Behavior
|
|
Strong
|
|
rs2242480
|
CYP3A4
*1G
|
Intronic variant in CYP3A4 intron 10 that upregulates a suppressive lncRNA, r...
|
Pharmacogenomics
|
|
Strong
|
|
rs2246709
|
CYP3A4
|
Intronic CYP3A4 variant associated with altered drug clearance, affecting met...
|
Pharmacogenomics
|
|
Moderate
|
|
rs2280275
|
CYP2J2
|
Intronic variant in CYP2J2 that tags reduced epoxyeicosatrienoic acid (EET) p...
|
Pharmacogenomics
|
|
Moderate
|
|
rs2289669
|
SLC47A1
MATE1 G-1853A
|
Intronic variant in MATE1, the renal and hepatic metformin efflux transporter...
|
Pharmacogenomics
|
|
Moderate
|
|
rs2480256
|
CYP2E1
|
3' UTR variant that increases CYP2E1 expression, raising hepatotoxicity risk ...
|
Pharmacogenomics
|
|
Moderate
|
|
rs8087522
|
MC4R
MC4R A/G (rs8087522)
|
Upstream regulatory variant near MC4R that may create a transcription factor ...
|
Appetite & Obesity
|
|
Emerging
|
|
rs2515641
|
CYP2E1
|
Synonymous exon-8 variant that reduces CYP2E1 mRNA and protein expression, al...
|
Pharmacogenomics
|
|
Moderate
|
|
rs887829
|
UGT1A1
UGT1A1*80
|
Promoter variant in UGT1A1 that tags the *28 reduced-expression haplotype; T ...
|
Vascular Inflammation & Remodeling
|
|
Strong
|
|
rs2740574
|
CYP3A4
*1B -392A>G
|
Promoter variant affecting CYP3A4 expression, most common in African populations
|
Pharmacogenomics
|
|
Moderate
|
|
rs63749869
|
RYR1
R4861H (Arg4861His)
|
RYR1 missense variant causing malignant hyperthermia susceptibility and centr...
|
Fitness & Body
|
|
Established
|
|
rs28371706
|
CYP2D6
*17
|
Decreased-function CYP2D6 allele common in African populations, reducing meta...
|
Pharmacogenomics
|
|
Established
|
|
rs78707713
|
TSPAN15
|
Intronic TSPAN15 variant that modulates ADAM10-mediated shedding of GPVI, the...
|
Coronary Artery Disease & Atherosclerosis
|
|
Strong
|
|
rs28371725
|
CYP2D6
*41
|
Intronic splice variant causing decreased CYP2D6 enzyme activity through aber...
|
Pharmacogenomics
|
|
Established
|
|
rs28371733
|
CYP2D6
|
Rare CYP2D6 stop-gain variant (Glu418Ter) that eliminates enzyme activity, ca...
|
Pharmacogenomics
|
|
Established
|
|
rs28371759
|
CYP3A4
*18 (L293R)
|
Rare missense variant causing a Leu293Arg substitution in CYP3A4, associated ...
|
Pharmacogenomics
|
|
Moderate
|
|
rs28399433
|
CYP2A6
*9 (TATA box)
|
Promoter variant that reduces CYP2A6 expression by ~50%, slowing nicotine met...
|
Pharmacogenomics
|
|
Strong
|
|
rs28399444
|
CYP2A6
*7 (I471T)
|
CYP2A6*7 missense variant that nearly abolishes nicotine C-oxidase activity; ...
|
Pharmacogenomics
|
|
Established
|
|
rs28695233
|
CYP2D6
|
Deep intronic CYP2D6 variant in intron 2 that serves as a haplotype tag in sp...
|
Pharmacogenomics
|
|
Emerging
|
|
rs2653349
|
HCRTR2
Ile308Val
|
Missense variant at position 308 of the orexin receptor 2 protein; the minor ...
|
Neurology & Cognition
|
|
Strong
|
|
rs316019
|
SLC22A2
Ala270Ser
|
Reduces OCT2 organic cation transporter function in the kidney, lowering metf...
|
Pharmacogenomics
|
|
Moderate
|
|
rs35599367
|
CYP3A4
*22
|
Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin...
|
Pharmacogenomics
|
|
Established
|
|
rs368234815
|
IFNL4
ss469415590 (TT/ΔG)
|
Causal frameshift polymorphism controlling IFNL4 protein production; the ΔG a...
|
Pharmacogenomics
|
|
Established
|
|
rs373489637
|
CYP2B6
V183G
|
Near-complete loss-of-function CYP2B6 variant causing severely impaired metab...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3758581
|
CYP2C19
Ile331Val (CYP2C19*1B)
|
Common CYP2C19 missense variant defining the *1B allele; the G (Val331) allel...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3765467
|
GLP1R
Arg131Gln
|
Missense variant in the GLP-1 receptor that alters drug response to GLP-1 ago...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3788189
|
SLC19A1
SLC19A1 IVS2 variant
|
Intronic variant in the folate transporter gene associated with pemetrexed tr...
|
Methylation & Detox
|
|
Emerging
|
|
rs3791033
|
KDM4A
|
Intronic variant in KDM4A histone demethylase associated with problematic opi...
|
Pharmacogenomics
|
|
Moderate
|
|
rs3814637
|
CYP2C19
|
Upstream CYP2C19 variant associated with altered R-warfarin clearance and inc...
|
Pharmacogenomics
|
|
Moderate
|
|
rs5030868
|
G6PD
G6PD Mediterranean
|
Severe Class II G6PD deficiency variant (c.563C>T, p.Ser188Phe) causing less ...
|
Blood Sugar & Diabetes
|
|
Established
|
|
rs3918290
|
DPYD
*2A
|
Most critical pharmacogenomic variant causing complete loss of DPD enzyme fun...
|
Pharmacogenomics
|
|
Established
|
|
rs5219
|
KCNJ11
E23K
|
Controls the pancreatic beta-cell potassium channel that regulates insulin se...
|
Blood Sugar & Diabetes
|
|
Strong
|
|
rs4148323
|
UGT1A1
*6 Gly71Arg
|
Phase II glucuronidation enzyme that metabolizes bilirubin and many drugs inc...
|
Pharmacogenomics
|
|
Established
|
|
rs6166
|
FSHR
Asn680Ser (N680S)
|
Affects FSH receptor sensitivity, determining ovarian response to FSH stimula...
|
Hormones & Sleep
|
|
Strong
|
|
rs4684059
|
HRH1
|
Intronic variant in the histamine H1 receptor gene associated with altered re...
|
Methylation & Detox
|
|
Emerging
|
|
rs4646438
|
CYP3A4
*6 (17776insA / frameshift)
|
Frameshift insertion in CYP3A4 exon 9 that produces a truncated, non-function...
|
Pharmacogenomics
|
|
Strong
|
|
rs4646976
|
CYP2E1
|
CYP2E1 intronic haplotype tag — affects enzyme activity and susceptibility to...
|
Pharmacogenomics
|
|
Moderate
|
|
rs4997557
|
CYP2A6
|
Rare CYP2A6 missense variant (p.Thr294Ile) that likely reduces nicotine-metab...
|
Pharmacogenomics
|
|
Emerging
|
|
rs5030655
|
CYP2D6
*6
|
Frameshift deletion causing no enzyme function, defining poor metabolizer sta...
|
Pharmacogenomics
|
|
Established
|
|
rs55785340
|
CYP3A4
*2
|
Missense variant reducing CYP3A4-mediated nifedipine clearance, causing eleva...
|
Pharmacogenomics
|
|
Moderate
|
|
rs55886062
|
DPYD
*13
|
No-function DPYD star allele (I560S) causing severe DPD deficiency; one of fo...
|
Pharmacogenomics
|
|
Established
|
|
rs55897648
|
CYP2E1
*3 (Val389Ile)
|
CYP2E1*3 missense variant with no demonstrated change in enzyme activity for ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs7202877
|
CTRB1
|
Intergenic variant near CTRB1/CTRB2 that regulates chymotrypsinogen expressio...
|
Blood Sugar & Diabetes
|
|
Strong
|
|
rs56038477
|
DPYD
HapB3 tag (c.1236G>A, E412E)
|
Synonymous exon-11 tag SNP for the DPYD HapB3 haplotype; benign on its own bu...
|
Pharmacogenomics
|
|
Established
|
|
rs76723693
|
G6PD
G6PD Nefza (c.968T>C)
|
Missense variant in glucose-6-phosphate dehydrogenase causing Class III G6PD ...
|
Blood Sugar & Diabetes
|
|
Strong
|
|
rs58194899
|
EIPR1
|
Intronic variant in EIPR1 (endosomal trafficking protein) associated with pai...
|
Pharmacogenomics
|
|
Emerging
|
|
rs58440431
|
CYP2D6
|
Intronic CYP2D6 variant tagging East Asian *10-lineage suballeles; the C alle...
|
Pharmacogenomics
|
|
Strong
|
|
rs622342
|
SLC22A1
A>C
|
Intronic variant in the OCT1 organic cation transporter reducing hepatic metf...
|
Pharmacogenomics
|
|
Moderate
|
|
rs640561
|
LRRIQ3
|
Intergenic variant near LRRIQ3 associated with problematic opioid prescriptio...
|
Pharmacogenomics
|
|
Emerging
|
|
rs6413419
|
CYP2E1
*4 (V179I)
|
Missense variant (Val179Ile) defining the CYP2E1*4 allele; associated with al...
|
Pharmacogenomics
|
|
Emerging
|
|
rs67376798
|
DPYD
D949V
|
Decreased-function variant reducing DPD enzyme activity ~30%, requiring 50% f...
|
Pharmacogenomics
|
|
Established
|
|
rs67784355
|
CYP3A4
*11 (Thr363Met)
|
Rare missense variant in CYP3A4 that reduces protein expression and enzymatic...
|
Pharmacogenomics
|
|
Emerging
|
|
rs67807361
|
CYP2C9
p.Leu19Ile
|
Rare CYP2C9 N-terminal missense variant of uncertain functional significance ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs6923761
|
GLP1R
Gly168Ser
|
GLP-1 receptor variant that alters response to GLP-1 agonist medications used...
|
Pharmacogenomics
|
|
Moderate
|
|
rs71328650
|
CYP2D6
|
Intronic CYP2D6 haplotype tag variant (rs28371702 canonical form) associated ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs72547511
|
CYP1A2
CYP1A2*15 (Pro42Arg)
|
Rare CYP1A2 missense variant at the critical Pro42 position; nearly abolishes...
|
Pharmacogenomics
|
|
Moderate
|
|
rs72547515
|
CYP1A2
*16 (Arg377Gln)
|
Nearly-inactive CYP1A2 missense variant — carriers have severely impaired met...
|
Pharmacogenomics
|
|
Moderate
|
|
rs6795209
|
HTR1F
|
Intergenic variant at the HTR1F locus on chromosome 3; the minor A allele inc...
|
Neurology & Cognition
|
|
Strong
|
|
rs72547516
|
CYP1A2
Ile386Val
|
Rare CYP1A2 missense variant (Ile386Val) associated with potentially reduced ...
|
Pharmacogenomics
|
|
Emerging
|
|
rs72547517
|
CYP1A2
*8
|
CYP1A2*8 — near-complete loss-of-function missense variant causing severely r...
|
Pharmacogenomics
|
|
Strong
|
|
rs72549354
|
CYP2D6
*20
|
Frameshift insertion creating a null CYP2D6 allele; carriers cannot metaboliz...
|
Pharmacogenomics
|
|
Established
|
|
rs75017182
|
DPYD
HapB3 (c.1129-5923C>G)
|
Deep intronic splice-site variant that is the functional driver of the DPYD H...
|
Pharmacogenomics
|
|
Established
|
|
rs776746
|
CYP3A5
*3
|
Splice site variant creating a non-functional CYP3A5 enzyme, dramatically aff...
|
Pharmacogenomics
|
|
Established
|
|
rs8192780
|
CYP2E1
|
Downstream regulatory variant near CYP2E1 associated with nasopharyngeal carc...
|
Pharmacogenomics
|
|
Emerging
|